According to Straits Research, the global smart insulin pens market size was valued at USD 98.3 Billion in 2022. It is projected to reach from USD XX Billion in 2023 to USD 249.4 Billion by 2031, growing at a CAGR of 10.9% during the forecast period (2023–2031).